← Insider buys
REPL

Replimune Group, Inc. · Healthcare

Chief Business Officer Pamela Esposito sold $375K of Replimune Group, Inc.

Sold$375,450
$25.03Price
15,000Shares
−6%Stake

What REPL did after the filing

Prices for REPL after this filing aren't in yet.

Traded Fri, Dec 9. Filed Tue, Dec 13, 3:01 PM ET, during the session. Not investment advice.